Comments (0) Have your say

Read full story

YOUNG people in their thousands are supporting a health trust?s Chlamydia screeing programme. NHS Mid Essex which covers Chelmsford, Maldon and Braintree has announced the campaign to encourage young people to be screened for the sexually transmitted

(more…)

vaginosis/intermediate flora (Gram stain), yeast (culture), hydrogen peroxide-producing (H2O2+) Lactobacillus colonization (culture), Trichomonas vaginalis (In-Pouch), Neisseria gonorrhoeae, and Chlamydia trachomatis (Amplicor PCR). CVL was tested for

(more…)

Conclusions  The prevalence of Trichomonas spp. was low and stable in both populations in the 4 years, indicating an equilibrium in terms of numbers of this agent in
Maringá, Paraná, Brazil. The results corroborate the hypothesis that SES may influence the epidemiology of trichomoniasis.
The prevalence of the infection increases with age, a phenomenon not observed with other sexually transmitted infections,
such as gonorrhoea or Chlamydia trachomatis.

(more…)

Surveys of New York State Pharmacists find that 63% support use of patient delivered partner therapy, and 78% do not want a behind the counter status for Chlamydia antibiotics.Page: 178DOI: 10.1097/OLQ.0b013e31818eb73cAuthors: McNutt, Louise-Anne PHD *; Davis, Christopher F. MPH *; Bednarczyk, Robert A. MS *; Fischer, Andrea MPH *; Zeolla, Mario PharmD +; Coles, Bruce F. DO *++ (Source: Sexually Transmitted Diseases)

(more…)

CONCLUSION
These data suggest that SLPI and elafin have a role in the innate immune defence of the Fallopian tube in infection and ectopic pregnancy. Their role is likely to include regulation of protease activity, wound healing and tissue remodelling. (Source: Human Reproduction) MedWorm Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.

(more…)

making sure its existing tests remain fresh,

Read full story

Authors: Jiang LJ, Wang M, Or YS
EDP-420 (EP-013420, S-013420) is a first-in-class bicyclolide (bridged bicyclic macrolide) currently in clinical development for the treatment of respiratory tract infections. It has good pre-clinical pharmacokinetic properties across multiple species and potent in vitro and in vivo activity against respiratory tract infection pathogens, including H. Influenzae, atypicals (e.g., Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila), and multi-drug resistant streptococci. The safety, tolerability, and pharmacokinetics of an orally administered EDP-420 suspension in 40 healthy adult subjects were assessed in a randomized, double-blind, placebo-controlled, ascending single-dose study. Eligible subjects were sequentially randomized into on…

(more…)

This study was conducted to determine the activity of iclaprim compared with trimethoprim and other commonly prescribed drug classes against a comprehensive collection of 156 Neisseria gonorrhoeae, including subsets of organisms resistant to beta-lactams and fluoroquinolones (>60%). Iclaprim (MIC(50/90), 4/8 mug/mL) was 16-fold more potent than trimethoprim (MIC(50/90), 64/>64 mug/mL), and medium growth supplements did not adversely influence activity. Lack of cross-resistances for iclaprim with other commonly used therapies could make iclaprim an alternative for several sexually transmitted diseases (gonococci, Chlamydia trachomatis).
PMID: 19216944 [PubMed - as supplied by publisher] (Source: Diagnostic Microbiology and Infectious Disease)

(more…)

Summary  Dizziness, chest discomfort, chest depression and dyspnea are a group of symptoms that are common complaints in clinical practice.
Patients with these symptoms are usually informed that while neurosis consequent to coronary heart disease is excluded nonetheless
they remain unhealthy with no rational explanation or treatment. 165 cases of these symptoms and 85 control subjects were
reviewed and underwent further medical history inquiry, routine EKG test and cardiac ultrasound examination. Thirty-five patients
received coronary artery angiography to exclude coronary heart disease. Serum myocardial autoantibodies against beta1-adrenoceptor,
alpha-myosin heavy chain, M2-muscarinic receptor and adenine-nucleotide translocator were tested, and inflammatory cytokines
and …

(more…)